Trump Warns Pregnant Women to Avoid Tylenol Unless Necessary on Truth Social

Breaking News: Trump Attacks Tylenol Again on Truth Social, Warning Pregnant Women In a latest social media post, former US President Donald Trump has urged pregnant women to avoid taking Tylenol unless absolutely necessary. The warning was issued via his Truth Social platform on Friday, sparking concerns among health experts and shares of parent company Kenvues plummeting. Timeline: The post was made at an unspecified time on Friday, with no further details provided by the former President's team. This is not the first time Trump has targeted Tylenol, having previously criticized the pain reliever in a 2022 speech. Immediate Impact and Response: Kenvues shares have slipped following the announcement, with investors expressing concern over the potential impact on sales. Health experts are urging caution, emphasizing that pregnant women should consult their doctors before taking any medication. Background Context: Tylenol is one of the most widely used pain relievers globally, with millions of people relying on it for relief from headaches and other aches. The World Health Organization (WHO) has previously acknowledged the importance of safe use of over-the-counter medications during pregnancy. What Happens Next: As the situation unfolds, health experts are urging pregnant women to consult their doctors before taking Tylenol or any other medication. Kenvues is expected to issue a statement addressing the concerns raised by Trump's post. In the meantime, shares of the company continue to slide on international markets. Global Perspective: The controversy surrounding Tylenol highlights ongoing debates about the safety and efficacy of over-the-counter medications during pregnancy. As health experts emphasize the importance of safe use, global regulators are expected to weigh in on the issue. Sources: BreakingInnovation Kenvues World Health Organization (WHO) Note: This article is a factual report based on confirmed information and does not contain any sensational or speculative content. *This story is developing. Information compiled from Forbes reporting.*